| Health Care Equipment & Supplies Industry | Healthcare Sector | Robert Talbot CEO | EXPM Exchange | CA58463C1014 ISIN |
| CA Country | - Employees | - Last Dividend | 20 Feb 2001 Last Split | - IPO Date |
Medical Services International, Inc. (MSI) is an enterprise that delves into various medically-related businesses through its subsidiaries. The company is notably active in the operation of medical facilities located on the picturesque island of Anguilla, in the British West Indies. These facilities are distinct in that they offer North American standard medical diagnostic services and dialysis, coupled with the leisurely allure of a Caribbean destination. Originally established under the name TRAC Industries, Inc., the company underwent a rebranding to Medical Resorts International, Inc., before settling on its current name in 2001. Medical Services International’s genesis traces back to 1988, and it proudly positions its headquarters in Edmonton, Canada. This evolution from its original focus reflects the company’s adaptive strategies and broadening service offerings to encompass a wider range of healthcare solutions.
The heart of MSI’s operations lies within its cutting-edge medical facilities on Anguilla, blending the carefree essence of a Caribbean vacation with the security of accessible, high-quality North American healthcare services. These establishments are centerpieces of the company, providing essential medical diagnostics and life-sustaining dialysis treatments to both locals and international visitors seeking both recreational and medical solace on the island.
Apart from its healthcare facilities, MSI has made significant strides in manufacturing state-of-the-art VScan rapid test kits. These kits represent a leap in initial point-of-care screening technology, offering swift and reliable detection of a range of serious health threats, including HIV 1 & 2, Hepatitis B and C, Tuberculosis, West Nile virus, and Dengue Fever. The convenience and efficiency of these tests stand as a testament to MSI’s commitment to broadening the accessibility of crucial diagnostic tools.
MSI is also engaged in the forward-looking domain of clinical research, under contract, to explore new experimental medical treatments. This facet of the company underscores a dedication not just to current healthcare needs but to the future of medical science. By participating in the development and validation of innovative treatments, MSI contributes to the broader medical community’s efforts to combat diseases and improve health outcomes globally.